Testing effectiveness (Phase 2)Study completedNCT00394433
What this trial is testing
Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Who this might be right for
Esophageal CancerStomach Cancer
Dana-Farber Cancer Institute 38